SQZ Biotechnologies Company

OTCPK:SQZB Rapporto sulle azioni

Cap. di mercato: US$678.3k

SQZ Biotechnologies Gestione

Gestione criteri di controllo 2/4

SQZ Biotechnologies Il CEO è Howard Bernstein, nominato in Nov2022, ha un mandato di 2.08 anni. possiede direttamente 0.2% delle azioni della società, per un valore di $ 1.37K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.9 anni e 4.1 anni.

Informazioni chiave

Howard Bernstein

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO2yrs
Proprietà del CEO0.2%
Durata media del management2.9yrs
Durata media del Consiglio di amministrazione4.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%

Jun 26
SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%

We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully

Jan 05
We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully

SQZ Biotechnologies GAAP EPS of -$0.77 beats by $0.06, revenue of $3.5M misses by $0.76M

Nov 09

SQZ Biotech spikes as H.C. Wainwright initiates with Buy citing platform technology

Oct 20

Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?

Aug 20
Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?

SQZ Biotechnologies GAAP EPS of -$0.78 misses by $0.01, revenue of $3.22M misses by $0.97M

Aug 04

SQZ Biotechnologies names business chief as CFO

Jul 11

Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook

May 17
Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook

Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

May 02
Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Jan 11
Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?

Jul 30
Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?

Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)

May 16
Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)

Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts

Mar 25
Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts

SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 20
SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth

Feb 01
We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Howard Bernstein rispetto agli utili di SQZ Biotechnologies?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2023n/an/a

-US$72m

Jun 30 2023n/an/a

-US$71m

Mar 31 2023n/an/a

-US$76m

Dec 31 2022US$2mUS$400k

-US$79m

Sep 30 2022n/an/a

-US$78m

Jun 30 2022n/an/a

-US$78m

Mar 31 2022n/an/a

-US$74m

Dec 31 2021US$1mUS$391k

-US$69m

Sep 30 2021n/an/a

-US$75m

Jun 30 2021n/an/a

-US$64m

Mar 31 2021n/an/a

-US$55m

Dec 31 2020US$750kUS$357k

-US$51m

Compensazione vs Mercato: Dati insufficienti per stabilire se la retribuzione totale di Howard sia ragionevole rispetto ad aziende di dimensioni simili nel mercato US.

Compensazione vs guadagni: La retribuzione di Howard è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Howard Bernstein (67 yo)

2yrs

Mandato

US$1,624,513

Compensazione

Dr. Howard Bernstein, M.D., Ph D., had been Chief Scientific Officer of SQZ Biotechnologies Company since June 2015 until October 31, 2022. Dr. Bernstein is Director of SQZ Biotechnologies Company since Oc...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Howard Bernstein
Interim CEO & Director2yrsUS$1.62m0.20%
$ 1.4k
Lawrence Knopf
General Counsel & Secretary5.2yrsUS$944.03k0.0066%
$ 44.6
Marshelle Warren
Chief Medical Officer2.4yrsUS$944.27k0%
$ 0
Robert Langer
Co-Founder & Member of Scientific Advisory Boardno dataNessun datoNessun dato
Richard Capasso
Chief Accounting Officer3yrsNessun datoNessun dato
David First
Chief People Officer4.5yrsNessun datoNessun dato
Ipsita Roymoulik
Senior Vice President of CMC & QUALITY2.8yrsNessun datoNessun dato

2.9yrs

Durata media

62yo

Età media

Gestione esperta: Il team dirigenziale di SQZB è considerato esperto (durata media dell'incarico 2.9 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Howard Bernstein
Interim CEO & Director2.1yrsUS$1.62m0.20%
$ 1.4k
Robert Langer
Co-Founder & Member of Scientific Advisory Boardno dataNessun datoNessun dato
David Sachs
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Amy W. Schulman
Directorno dataUS$104.40k0.74%
$ 5.0k
Patrick V. J. Vink
Independent Director3.3yrsUS$96.62k0%
$ 0
Klavs Jensen
Independent Director11.7yrsUS$89.40k1.15%
$ 7.8k
Bernard Coulie
Independent Chairman3.3yrsUS$94.40k0%
$ 0
Marc Elia
Independent Director6.5yrsUS$86.90k0%
$ 0
Darrell Irvine
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Pushkal Garg
Independent Director6.3yrsUS$94.40k0%
$ 0
Marc Schegerin
Independent Director4.1yrsUS$94.40k0%
$ 0
Arlene Sharpe
Member of Scientific Advisory Boardno dataNessun datoNessun dato

4.1yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SQZB sono considerati esperti (durata media dell'incarico 4.1 anni).